The Net Margin of Epigenomics AG (ECX.DE) is -2479.18%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2022-12-31 | -2479.18% |
| 2021-12-31 | -39.14% |
| 2020-12-31 | -1387.89% |